We provide guidance to healthcare companies wishing to establish and develop in the French market.

The complexity, specificity and characteristics of this market mean this guidance is invaluable. We can offer this consultancy thanks to our extensive knowledge of the environment and its key players (Decision makers, assessment agencies, payers, buyers, patient associations).

We help our clients to define the best strategies pre- and post-launch in market, to assess opportunities and barriers, and to identify the key players at a national and regional level.

We also advise biotech companies on how to assess the product development potential among prescribers from preclinical phases.

Our team includes market research specialists as well as an expert panel per specialty (GPs, specialists, pharmacists, economists, jurists, statisticians, architects, engineers).